Rebeccamycin
Rebeccamycin, an antitumor antibiotic, inhibits DNA topoisomerase I. Rebeccamycin appears to exert its primary antineoplastic effect by poisoning topoisomerase I and has negligible effect on protein kinase C and topoisomerase. Reference standards of Rebeccamycin API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Rebeccamycin
[catalogue_number] => PA 18 1760000
[category_ids] => ,78,70,82,170,
[chemical_name] =>
[weight] => 570.38
[form] => C27H21Cl2N3O7
[cas] => 93908-02-2
[pslug] => 93908-02-2-rebeccamycin-pa181760000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Catalogue No.:PA 18 1760000
Molecular Formula : C27H21Cl2N3O7
Molecular Weight : 570.38